MTOR and metabolic dysfunction-associated steatohepatitis: In HucMSC-Ex treatment group at 6W or 8W, exosome increased p-AMPK protein levels and inhibited p-mTOR levels compared with the NASH group (Supplementary Fig. 13 online, p < 0.05).